Biotech company Small Pharma Inc. (OTCQB: DMTTF), producer of short-acting psychedelic-assisted therapies for diverse mental health conditions, announced its financial results earlier this month for the fiscal year ended Feb. 28, 2022.
The company’s numbers up to closing date:
- Cash available totaled CA$40.7 million ($31.3 million).
- Cash used in yearly business activities added up to CA$16.2 million ($12.4 million).
- Operating expenses for the 12 months summed $18.1 million ($13.9 million).
The company is providing option grants for up to an aggregate of …